We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer

By MedImaging International staff writers
Posted on 20 Mar 2024
Print article
Image: PET imaging could allow examination of tumors in more detail while they are still growing (Photo courtesy of University of Glasgow)
Image: PET imaging could allow examination of tumors in more detail while they are still growing (Photo courtesy of University of Glasgow)

Biopsies, the current method for diagnosing bowel cancer, are invasive and come with risks like possible infection. While precision medicine has the potential to revolutionize cancer diagnosis and treatment, the development of accurate, informative, and patient-friendly diagnostic techniques is vital for its success. Now, new research has revealed that PET (Positron Emission Tomography) imaging could provide a ground-breaking approach to diagnosing and treating bowel cancer, enabling the application of precision medicine to oncology.

New research from the University of Glasgow (Scotland, UK) has found that PET imaging technology could revolutionize bowel cancer diagnosis and treatment. PET scans can examine the entire bowel and study tumors internally, avoiding the need to remove and examine tumor tissue externally. This technique uses special tracers to produce three-dimensional images of the body's interior, highlighting areas of abnormal cell activity. The technology could align bowel cancer treatment with precision medicine, ensuring patients receive the most effective treatments for their specific condition. Moreover, undergoing multiple PET scans could allow physicians to monitor the cancer's progress and the treatment's effectiveness over time.

The Glasgow team utilized existing genetic information about bowel cancer to identify distinct tumor characteristics through PET imaging. They found that employing multiple PET tracers, instead of just one, could differentiate between various types of bowel cancer in mice, based on their genetic makeup. This approach could lead to personalized patient care, as treatments could be customized according to each patient's specific cancer type. Since patients' bowel cancers can have unique mutations, such as in the KRAS, APC, and TGFB genes, which produce different imaging signatures, PET imaging has the potential to quickly identify the type of bowel cancer a patient has. This could significantly expedite access to the most suitable treatment for their disease, marking a significant step forward in the application of precision medicine to oncology.

“Precision medicine has the potential to revolutionize cancer diagnosis and treatment. However, the development of accurate, informative, and patient-friendly diagnostic techniques is crucial for its success,” said Dr. David Lewis, of the Cancer Research UK Scotland Institute and the University of Glasgow, who led the research. “PET imaging offers a promising alternative, with the ability to survey the entire cancer landscape, allowing us to examine tumors in more detail while they are still growing.”

Related Links:
University of Glasgow

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Pre-Op Planning Solution
Sectra 3D Trauma
New
Drape Barrier
Double Pivot Swing Arm Drape
New
Color Doppler Ultrasound System
DCU50

Print article
Radcal

Channels

MRI

view channel
Image: The artificial intelligence model outperformed clinical tests at predicting the progress of Alzheimer’s disease (Photo courtesy of 123RF)

AI Outperforms Clinical Tests at Predicting Alzheimer’s Progress from MRI Scans

Dementia is a major global health challenge, impacting over 55 million individuals worldwide and costing approximately USD 820 billion annually. Projections indicate that the number of cases will nearly... Read more

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.